We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$998M
AUM Growth
+$225M
Cap. Flow
+$186M
Cap. Flow %
18.64%
Top 10 Hldgs %
14.67%
Holding
843
New
316
Increased
131
Reduced
122
Closed
270

Sector Composition

Rank Sector Weight
1 Healthcare 19.66%
2 Consumer Discretionary 12.61%
3 Technology 12.15%
4 Financials 10.74%
5 Communication Services 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKSD
526
DELISTED
LSC Communications, Inc.
LKSD
$226K 0.02%
+8,978
New +$235K
EPAY
527
DELISTED
Bottomline Technologies Inc
EPAY
$225K 0.02%
+9,551
New +$241K
TTWO icon
528
Take-Two Interactive
TTWO
$46.1B
$223K 0.02%
3,757
-37,504
-91% -$2.09M
NWBI icon
529
Northwest Bancshares
NWBI
$2.33B
$218K 0.02%
12,951
+1,821
+16% +$31.9K
CCI icon
530
Crown Castle
CCI
$34.6B
$217K 0.02%
+2,294
New +$205K
ORA icon
531
Ormat Technologies
ORA
$5.8B
$217K 0.02%
+3,796
New +$210K
ATO icon
532
Atmos Energy
ATO
$29.7B
$216K 0.02%
2,735
-11,433
-81% -$877K
NXPI icon
533
NXP Semiconductors
NXPI
$60.8B
$215K 0.02%
2,077
-2,923
-58% -$296K
PAGP icon
534
Plains GP Holdings
PAGP
$5.28B
$215K 0.02%
+6,890
New +$224K
PVTB
535
DELISTED
PrivateBancorp Inc
PVTB
$215K 0.02%
+3,617
New +$203K
UFS
536
DELISTED
DOMTAR CORPORATION (New)
UFS
$214K 0.02%
+5,860
New +$232K
LJPC
537
DELISTED
La Jolla Pharmaceutical Company
LJPC
$214K 0.02%
+7,182
New +$183K
TWI icon
538
Titan International
TWI
$492M
$213K 0.02%
+20,613
New +$245K
GBCI icon
539
Glacier Bancorp
GBCI
$6.36B
$212K 0.02%
+6,243
New +$221K
PRXL
540
DELISTED
Parexel International Corp
PRXL
$212K 0.02%
+3,356
New +$222K
HZN
541
DELISTED
Horizon Global Corporation
HZN
$211K 0.02%
+15,222
New +$278K
BEAV
542
DELISTED
B/E Aerospace Inc
BEAV
$211K 0.02%
+3,296
New +$207K
SRCL
543
DELISTED
Stericycle Inc
SRCL
$208K 0.02%
+2,505
New +$201K
FITB
544
Fifth Third Bancorp
FITB
$51.3B
$206K 0.02%
+8,096
New +$216K
ZYNE
545
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$205K 0.02%
+10,162
New +$202K
MRC
546
DELISTED
MRC Global
MRC
$204K 0.02%
+11,150
New +$221K
TKR icon
547
Timken Company
TKR
$9.19B
$203K 0.02%
4,506
-4,209
-48% -$186K
NAV
548
DELISTED
Navistar International
NAV
$203K 0.02%
+8,247
New +$227K
FOLD
549
DELISTED
Amicus Therapeutics
FOLD
$197K 0.02%
+27,611
New +$175K
VXX
550
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$197K 0.02%
+3,125
New +$232K

Similar funds

Schonfeld Strategic Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Schonfeld Strategic Advisors held 843 positions worth $998M, up 29% from $772M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Schonfeld Strategic Advisors deployed $186M of net new capital in Q1 2017, opening 316 new positions and adding to 131 existing holdings. Its largest new stake was AMC Entertainment Holdings: 113,380 shares worth $35.7M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $8.19M trimmed.

  • Schonfeld Strategic Advisors's largest Q1 2017 buy was AMC Entertainment Holdings: 113,380 shares worth $35.7M.
  • Schonfeld Strategic Advisors added most to Athene Holding Ltd. Class A Common Shares in Q1 2017, an estimated $16.5M increase.
  • Schonfeld Strategic Advisors's biggest Q1 2017 reduction was AbbVie, cutting an estimated $8.19M.
  • Schonfeld Strategic Advisors fully exited Independence Realty Trust in Q1 2017, selling an estimated $8.78M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 15% of its $998M portfolio in Q1 2017.
  • Schonfeld Strategic Advisors opened 316 new positions and closed 270 in Q1 2017.
  • Schonfeld Strategic Advisors's portfolio value rose 29% quarter-over-quarter to $998M.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2017, filed 15 May 2017.